Abbott Laboratories buy BTIG Research
Start price
20.11.25
/
50%
€107.90
Target price
20.11.26
€125.82
Performance (%)
-15.29%
Price
20.03.26
€91.40
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.29%. This prediction currently runs until 20.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.413% | -3.413% |
| iShares Core DAX® | -4,93 % | -11,98 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % |
| iShares S&P 500 | -2,54 % | -3,54 % |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€95.00
18.02.26
18.02.26
€118.19
18.02.27
18.02.27
-3.79%
20.03.26
20.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
-1.74%
20.03.26
20.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.96
16.10.25
16.10.25
€124.21
16.10.26
16.10.26
-17.63%
20.03.26
20.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-12.69%
20.03.26
20.03.26